Acta Med. 2017, 60: 44-50
https://doi.org/10.14712/18059694.2017.49
Papillary Thyroid Carcinoma: Analysis of the Central Compartmentʼs Lymph Nodes Metastases
References
1. BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26(1): 1–133.
<https://doi.org/10.1089/thy.2015.0020>
<PubMed>
2. JD, Panzarella T, Tsang RW, et al. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example. Cancer 1997; 79(12): 2414–2423.
<https://doi.org/10.1002/(SICI)1097-0142(19970615)79:12<2414::AID-CNCR18>3.0.CO;2-U>
3. G, Teixeira T, Gubert F, et al. The incidence of central neck micrometastasis disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0. Surgery 2011; 150(6): 1161–1167.
<https://doi.org/10.1016/j.surg.2011.09.019>
4. V, Hitier M, Bedfert C, et al. Predictive factors for lateral occult lymph node metastasis in papillary thyroid carcinoma. Eur Arch otorhinolaryngol 2013; 270(7): 2095–2100.
<https://doi.org/10.1007/s00405-012-2305-z>
5. KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007; 246(3): 375–381.
<https://doi.org/10.1097/SLA.0b013e31814697d9>
<PubMed>
6. V, Feurer ID, Griffin MR, et al. The impact of lymph node involvement on survival in patients with papillary and folicular thyroid carcinoma. Surgery 2008; 144(6): 1070–1078.
<https://doi.org/10.1016/j.surg.2008.08.034>
7. DM, Mamelle E, Borget I, et al. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg 2013; 37(8): 1951–1958.
<https://doi.org/10.1007/s00268-013-2089-3>
8. S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005; 90(10): 5723–5729.
<https://doi.org/10.1210/jc.2005-0285>
9. TP, van Tol KM, Jager PL, et al. Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer 2005; 12(2): 273–280.
<https://doi.org/10.1677/erc.1.00892>
10. M, Sojak J, Slašťan M, et al. Papilárny karcinóm štítnej žľazy: Analýza veľkosti primárneho tumoru, infiltrácie puzdra štítnej žľazy a lymfangioinvázie vzhľadom k lokoregionálnemu metastázovaniu a veku. Otorinolaryng a Foniat (Praque) 2016; 65(4): 224–231.
11. H, Ito Y, Okamoto T, et al. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg 2011; 35(1): 111–121.
<https://doi.org/10.1007/s00268-010-0832-6>
12. T, Carty SE, Ciarleglio MM, et al. American thyroid association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 2012; 22(3): 237–243.
<https://doi.org/10.1089/thy.2011.0317>
13. NF, Cantor SB, Sherman SI, et al. Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 2001; 130(6): 921–930.
<https://doi.org/10.1067/msy.2001.118370>
14. N, Lassalle S, Benaim G, et al. Role of frozen section analysis in nodular thyroid pathology. Eur Ann Otorhinolaryngol Head Neck Dis 2015; 132(2): 67–70.
<https://doi.org/10.1016/j.anorl.2014.02.006>
15. L, Panieri E. Pre-operative diagnosis of thyroid cancer: clinical, radiological and pathological correlation. S Afr J Surg 2013; 51(2): 46–49.
<https://doi.org/10.7196/sajs.1261>
16. Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003; 13(4): 381–387.
<https://doi.org/10.1089/105072503321669875>
